Atara Biotherapeutics Inc... (ATRA)
NASDAQ: ATRA
· Real-Time Price · USD
8.05
-0.53 (-6.18%)
At close: Jun 17, 2025, 1:50 PM
-6.18% (1D)
| Bid | 8.03 |
| Market Cap | 54.74M |
| Revenue (ttm) | 101.58M |
| Net Income (ttm) | -15.64M |
| EPS (ttm) | -2.26 |
| PE Ratio (ttm) | -3.56 |
| Forward PE | -6.48 |
| Analyst | Buy |
| Ask | 8.19 |
| Volume | 18,122 |
| Avg. Volume (20D) | 58,976 |
| Open | 8.38 |
| Previous Close | 8.58 |
| Day's Range | 8.02 - 8.38 |
| 52-Week Range | 5.00 - 18.70 |
| Beta | 0.18 |
About ATRA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ATRA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ATRA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+15.13%
Atara Biotherapeutics shares are trading higher af...
Unlock content with
Pro Subscription
1 month ago
+5.79%
Atara Biotherapeutics shares are trading higher after the company provided updates on EBVALLO and announced the FDA has lifted its clinical hold to resume the clinical trials.
